D

IBM and Du Pont; Eastman Kodak, Hewlett-Packard, and Upjohn: just a few of tile U.S. corporations famous for being on the cutting edge of scientific research. And although each of these companies has long operated across international boundaries, this research has traditionally been conducted within the U.S. Increasingly, however, that is changing. In the past five years, all of these industry leaders have opened research facilities in Europe or Japan— regarding a new era of truly mult

Written byRobert Buderi
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

IBM and Du Pont; Eastman Kodak, Hewlett-Packard, and Upjohn: just a few of tile U.S. corporations famous for being on the cutting edge of scientific research. And although each of these companies has long operated across international boundaries, this research has traditionally been conducted within the U.S. Increasingly, however, that is changing. In the past five years, all of these industry leaders have opened research facilities in Europe or Japan— regarding a new era of truly multinational industrial research.

And these firms aren’t alone. The National Science Foundation reports that U.S. corporations as a group are spending an increasing amount of money on overseas research. In 1985, according to NSF figures, U.S. firms spent $3.7 billion on R&D abroad, versus $5 1.4 billion at home. By the end of 1986, overseas research had grown some 27%, to $4.7 billion, while domestic research was up just 6.5%, to $52.8 billion. And ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies